Navigation Links
Halozyme Provides HYLENEX® Product Reintroduction Update
Date:8/31/2010

th the child and caregiver, such as in the child's upper back, while the child is held by a parent. Once HYLENEX has been injected, fluids can be administered subcutaneously.

About Halozyme Halozyme Therapeutics is a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the endocrinology, oncology, dermatology and drug delivery markets. The company's product portfolio is based primarily on intellectual property covering the family of human enzymes known as hyaluronidases and additional enzymes that affect the extracellular matrix. Halozyme's Enhanze™ technology is a novel drug delivery platform designed to increase the absorption and dispersion of biologics. The company has key partnerships with Roche to apply Enhanze technology to Roche's biological therapeutics, including Herceptin® and MabThera®, for up to 13 targets, and with Baxter BioScience to apply Enhanze technology to GAMMAGARD Liquid®. Halozyme's Ultrafast Insulin program combines its rHuPH20 enzyme with mealtime insulins, which may produce more rapid absorption, faster action, and improved glycemic control. The product candidates in Halozyme's pipeline target multiple areas of significant unmet medical need. For more information visit www.halozyme.com.

Safe Harbor Statement In addition to historical information, the statements set forth above include forward-looking statements (including, without limitation, statements concerning the commercialization of HYLENEX) that involve risk and uncertainties that could cause actual results to differ materially from those in the
'/>"/>

SOURCE Halozyme Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Halozyme Therapeutics Completes Enrollment in Chemophase Phase I/IIa Clinical Trial for Superficial Bladder Cancer
2. Halozyme Therapeutics Announces Peer-Reviewed Publications of the INFUSE-LR Clinical Trial Results and Clinical Practice Experience With Hylenex
3. Halozyme Therapeutics Presents Pre-Clinical Studies of Systemic Delivery of Pegylated rHuPH20 Enyzme in Prostate Cancer Models at American Association for Cancer Research Conference
4. Halozyme Therapeutics Presents Findings on Combinations of rHuPH20 Enzyme With Bisphosphonates at the American Association for Cancer Research Conference
5. Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability
6. Halozyme Therapeutics Announces That Chemophase Meets Primary Endpoint in Phase I/IIa Clinical Trial
7. Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models
8. Halozyme Therapeutics Announces Roche Begins Phase 1 Clinical Trial and Selects Fourth Exclusive Biologic Target
9. Halozyme Therapeutics Begins Phase 1 Clinical Trial of Bisphosphonate Administered With rHuPH20 Enzyme
10. CuraGen Provides Update on Velafermin, Belinostat and CR011-vcMMAE Clinical Development Programs
11. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... June 2, 2015 The Canadian Society for Vascular ... tests, treatments or procedures that are commonly ordered ... part of Choosing Wisely Canada.  The list identifies ... conversations between patients and physicians about what care ... for Vascular Surgery,s list identified the following five ...
(Date:6/2/2015)... FORT WORTH, Texas , June 2, 2015 ... simulation market report defines and segments the concerned ... market was valued at $261.8 million in 2014, ... 2019, at a CAGR of 19.3% from 2014 ... of North America Mannequin-Based Simulation Market for an ...
(Date:6/2/2015)... Research and Markets ( http://www.researchandmarkets.com/research/g5r2nj/surgical_incision ) has announced ... Strategic Business Report" report to their offering. ... Canada , Japan , ... Latin America , and Rest of World. ... Closures in US$ Million by the following Product Segments: Stapler ...
Breaking Medicine Technology:As part of the Choosing Wisely Canada campaign the Canadian Society for Vascular Surgery releases list of commonly used tests and treatments to question 2As part of the Choosing Wisely Canada campaign the Canadian Society for Vascular Surgery releases list of commonly used tests and treatments to question 3As part of the Choosing Wisely Canada campaign the Canadian Society for Vascular Surgery releases list of commonly used tests and treatments to question 4North America Mannequin-Based Simulation Market is Expected to Reach $632.5 Million by 2019, at a CAGR of 19.3% From 2014 to 2019 2North America Mannequin-Based Simulation Market is Expected to Reach $632.5 Million by 2019, at a CAGR of 19.3% From 2014 to 2019 3Surgical Incision Closures - Global Strategic Business Report 2015 2
(Date:6/2/2015)... June 02, 2015 IMPAK Corporation, ... systems, has announced the availability of “child-resistant” pouches ... poisons by children, especially curious toddlers. The Child ... and tested to CFR 1700.20 protocols. The announcement ... , Looks Like Candy, “With the proliferation of ...
(Date:6/2/2015)... ZOOM+, the Portland-based health innovator of on-demand ... today the opening of its on-demand ZOOM+Smile studio. ZOOM+Smile ... complete dental exam, cleaning and whitening in 57 minutes, ... ZOOM+ services, ZOOM+Smile can be scheduled by mobile phone ... be as inviting as your favorite coffee shop?” said ...
(Date:6/2/2015)... 2015 MAP Health Management, LLC, a ... management for addiction treatment facilities, announced today that Jared ... Marketing. Mr. Smith will be responsible for developing and ... visibility of MAP’s core message, products and initiatives. , ... Manager at Cottonwood Financial in Irving, Texas, where he ...
(Date:6/2/2015)... BRANFORD, CT (PRWEB) June 02, 2015 Acara ... launching websites that are responsive to mobile devices, as is ... “Many of our current clients, as well as several new ... to develop a responsive website for them to meet Google’s ... is also the case with our clients in education, non-profits, ...
(Date:6/2/2015)... 2015 With a dedicated focus to become ... Care has hired Leslie Young as director of human ... initiatives to better understand and respond to the distinct needs ... communities in 13 states across the country. , “As we ... support to our residents, we are making it an equal ...
Breaking Medicine News(10 mins):Health News:IMPAK Introduces Child Resistant Zip Pouches & Bags 2Health News:ZOOM+ Opens Its First On-Demand ZOOM+Smile Studio and Reinvents the Dental Exam 2Health News:Jared Smith Joins MAP Health Management, LLC, as Vice President of Marketing 2Health News:Acara Partners Expands Website and Digital Offerings 2Health News:Tutera Senior Living & Health Care Hires HR Pro Leslie Young to Lead New Initiatives to Become Employer of Choice 2Health News:Tutera Senior Living & Health Care Hires HR Pro Leslie Young to Lead New Initiatives to Become Employer of Choice 3Health News:Tutera Senior Living & Health Care Hires HR Pro Leslie Young to Lead New Initiatives to Become Employer of Choice 4
... China, April 13 Sinobiopharma, Inc. (OTC Bulletin Board: ... the sales contracts totaling 1.5 million units for its ... is China,s top-selling pre-surgical skeletal muscle relaxant. , ... exciting time for the company," said Sinobiopharma CEO, Dr. ...
... Group and Henry Ford Health System are ... Workshop" on April 16, 2009 at the Ramada Plaza, ... locals about autism spectrum disorder and developmental disabilities. Parents, ... opportunity to hear from several local experts on a ...
... nuts, and ,Mediterranean, fare most beneficial, researchers find ... nuts and the so-called "Mediterranean" diet are heart-friendly, ... glycemic index can harm your heart, say researchers ... 2007. , The studies included 146 prospective ...
... of antidepressants makes little difference, study finds , , MONDAY, ... that people with heart disease caused by blockage of ... finds. , That finding was to be expected, said ... in Murray, Utah, and lead author of the study, ...
... IT FundingCHICAGO, April 13 Critical care patients ... less likely now to develop complications and have ... health system implemented an advanced information technology system. ... 2006-2008 at 13 Resurrection ICUs, presented last week ...
... a view of nationalized health care - Tuesday, April 14 at ... Reports" takes a look into the state of universal health care ... that has been in place in that country since 1984. ... - from the health care system north of our border as ...
Cached Medicine News:Health News:Sinobiopharma, Inc. Signs Sales Contract for Flagship Project 2Health News:Metro Parent's Second Annual 'Living With Autism Workshop' Features Local Experts Who Are Intimately Involved in Improving the Lives of These Special Children 2Health News:Review Confirms Links Between Diet, Heart Health 2Health News:Heart Disease and Depression Up Heart Failure Risk 2Health News:Resurrection Health Uses Information Technology to Address Critical Care Crisis 2Health News:HDNet's 'Dan Rather Reports' Investigates the Possibility of a Better Health Care System North of the Border 2Health News:HDNet's 'Dan Rather Reports' Investigates the Possibility of a Better Health Care System North of the Border 3
BETASEPT® Scrub 4% is for surgical handscrubbing, healthcare personnel hand-washing, preoperative patient prepping and general skin degerming....
... Biosoft plus Neu ... spectrum anti-infective alcohol hand ... added ingredients of the ... has been clinically proven ...
... of waterless alcohol hand sanitizers like Aplicare ... soap and water as the recommended product ... 2002 CDC Draft Guidelines for hand hygiene., ... associated infections can be prevented with better ...
Hand antisepsis plays a significant role in preventing nosocomial infections and the associated morbidity, mortality and costs. 3M offers healthcare providers effective hand antisepsis products that ...
Medicine Products: